The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis
Open accessAbstract
As indicators of responsiveness to a tumour necrosis factor (TNF)α blocking agent (infliximab) are lacking in rheumatoid arthritis, we have used gene profiling in peripheral blood mononuclear cells to predict a good versus poor response to infliximab. Thirty three patients with very active disease (Disease Activity Score 28 >5.1) that resisted weekly methotrexate therapy were given infliximab at baseline, weeks 2 and 6, and every 8th week thereafter. The patients were categorized as responders if a change of Disease Activity Score 28 = 1.2 was obtained at 3 months. Mononuclear cell RNAs were collected at baseline and at three months from responders and non-responders. The baseline RNAs were hybridised to a microarray of 10,000 non-redundant human cDNAs. In 6 responders and 7 non-responders, 41 mRNAs identified by microarray analysis were expressed as a function of the response to treatment and an unsupervised hierarchical clustering perfectly separated these responders from non-responders. The informativeness of 20 of these 41 transcripts, as measured by qRT-PCR, was re-assessed in 20 other patients. The combined levels of these 20 transcripts properly classified 16 out of 20 patients in a leave-one-out procedure, with a sensitivity of 90% and a specificity of 70%, whereas a set of only 8 transcripts properly classified 18/20 patients. Trends for changes in various transcript levels at three months tightly correlated with treatment responsiveness and a down-regulation of specific transcript levels was observed in non-responders only. Our gene profiling obtained by a non-invasive procedure should now be used to predict the likely responders to an infliximab/methotrexate combination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microarray data analysis: from disarray to consolidation and consensus
Allison, D. B., Cui, X., Page, G. P., & Sabripour, M. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1749 · Cited by 1,339
Cited by
Cells of the synovium in rheumatoid arthritis. Macrophages
Kinne, R. W., Stuhlmüller, B., & Burmester, G.-R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2333 · Cited by 300
The peripheral-blood transcriptome: new insights into disease and risk assessment
Mohr, S., & Liew, C.-C. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.08.003 · Cited by 295
Mehta, D., Raison, C. L., Woolwine, B. J., Haroon, E., Binder, E. B., Miller, A. H., & Felger, J. C. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.04.004 · Cited by 74
Julià, A., Gómez, A., López-Lasanta, M., Blanco, F., Erra, A., Fernández-Nebro, A., Mas, A. J., Pérez-García, C., Vivar, M. L. G., Sánchez-Fernández, S., et al. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104053 · Cited by 24
Metadata
- Authors
- Lequerré, T., Gauthier-Jauneau, A.-C., Bansard, C., Derambure, C., Hiron, M., Vittecoq, O., Daveau, M., Mejjad, O., Daragon, A., Tron, F., Le Loët, X., & Salier, J.-P.
- Venue
- Arthritis Research & Therapy
- Published
- 2006-07-03
- Volume
- 8
- Issue
- 4
- Pages
- R105-R105
- ISSN
- 1478-6354 (ISSN-L)
- OpenAlex
- W2113990193
- Cited by
- 168
- References
- 1
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis. https://app.cochat.ai/papers/10.1186/ar1990
- The paper
- Lequerré, T., Gauthier-Jauneau, A.-C., Bansard, C., Derambure, C., Hiron, M., Vittecoq, O., Daveau, M., Mejjad, O., Daragon, A., Tron, F., Le Loët, X., & Salier, J.-P. (2006). Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis. Arthritis Research & Therapy. https://doi.org/10.1186/ar1990
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.